semaglutide vs tirzepatide cardiovascular dulaglutide vs ❇️ Outcomes with versus in Type 2 Diabetes 🟠BACKGROUND Tirzepatide, a dual incretin agonist of the glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors, has Comparative safety and side effects

Excluding Shapiro (2025) yielded a pooled log RR of 0.287 (95% CI: 0.0180.557)

If prescribed, members also receive: A personalized treatment plan 1:1 health coaching Ongoing support from healthcare providers Insurance concierge services to help navigate tirzepatide coverage (Note: Ro offers access to Zepbound single-dose pens, single-dose vials, and multi-dose Kwikpens, but not Mounjaro.) Zepbound and Mounjaro work best alongside diet and exercise

By contrast, Human pharmacokinetics remain undefined

Compounded versions are not FDA-approved and have not been individually evaluated by the FDA for safety

Like GLP-1 medications, they can promote modest weight loss and provide cardiovascular benefits, but they work through an entirely different mechanism

PMID: 7 ZafarAKhatoonSKhanMJAbuJNaeemA